Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03544190
Other study ID # UW18-012
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 28, 2018
Est. completion date December 31, 2020

Study information

Verified date November 2020
Source The University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to translate the original English version of Resilience Scale for Children (RS10) into traditional Chinese. It will then test the psychometric properties of the newly translated RS10.


Description:

It has been well documented that cancer and its treatment may have adverse effects on the physical and psychological well-being of children with cancer. Such adverse effects may start from diagnosis and continue for months or even years after the completion of therapy. Cancer and its treatments may also have long-term effects on the psychological well-being of children with cancer, such as decreased self-esteem, increased anxiety and depression that can adversely affect their quality of life. Numerous studies indicated that resilience effectively prevents the development of mental health problems and is associated with positive mental health outcomes in children and adolescents, such as reduced levels of anxiety, depression and obsessive compulsive symptoms. Assessing resilience in children with cancer is therefore crucial for a thorough understanding of their responses to stress and adversity, which is an essential prerequisite for the design of an appropriate psychological intervention to enhance their resilience and foster the development of their coping mechanisms and positive mental well-being. This study aims to translate the original English version of Resilience Scale for Children (RS10) into traditional Chinese. It will then test the psychometric properties of the newly translated RS10. In addition, the factorial structure of RS10 will be examined using confirmatory factor analysis (CFA).


Recruitment information / eligibility

Status Completed
Enrollment 186
Est. completion date December 31, 2020
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group 7 Years to 14 Years
Eligibility Inclusion Criteria: 1. ages between 7 and 14; 2. diagnosed with cancer within the previous 6 months and currently undergoing active treatments; 3. able to speak Cantonese and read Chinese. Exclusion Criteria: - Those children with cognitive and learning problems identified from their medical records will be excluded.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Hong Kong The University of Hong Kong Hong Kong

Sponsors (1)

Lead Sponsor Collaborator
The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Resilience level The Resilience Scale for Children (RS10) was developed to measure a child's capacity to respond to the life changes. The RS10 measures the child's resilience capacity along five core elements: (1) Sense of purpose and meaning, (2) Authenticity, (3) Equanimity, (4) Self-Reliance, and (5) Perseverance. Baseline
Secondary Number of depressive symptoms The subjects' depressive symptoms will be assessed using the Chinese version of the CES-DC. The CES-DC comprises 20 fully standardized items to evaluate depressive symptoms. All items are evaluated on a four-point self-report scale in relation to their incidence during the last week, which were scored from 0 to 3, with total possible scores ranging from 0 to 60, with higher scores indicating greater symptomatology. Baseline
Secondary Levels of self-esteem The subjects' self-esteem will be assessed using the Chinese version of the RSES. The RSES is designed to measure the global self-esteem of children and adolescents. The scale comprises 10 items, rated using a 4-point Likert scale ranging from 1 to 4, with total possible scores ranging from 10 to 40. Higher scores indicate higher levels of self-esteem. Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05584930 - Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN) N/A
Active, not recruiting NCT05202925 - Musical Training Programme to Improve Neurocognitive Functioning of Children Surviving Brain Tumours N/A
Recruiting NCT03472807 - EXOme Rare Cancers in Children (EXOCARE) N/A